Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - Sucampo Pharmaceuticals, Inc. | exh_322.htm |
| EX-32.1 - EXHIBIT 32.1 - Sucampo Pharmaceuticals, Inc. | exh_321.htm |
| EX-31.2 - EXHIBIT 31.2 - Sucampo Pharmaceuticals, Inc. | exh_312.htm |
| EX-31.1 - EXHIBIT 31.1 - Sucampo Pharmaceuticals, Inc. | exh_311.htm |
| EX-23.2 - EXHIBIT 23.2 - Sucampo Pharmaceuticals, Inc. | exh_232.htm |
| EX-23.1 - EXHIBIT 23.1 - Sucampo Pharmaceuticals, Inc. | exh_231.htm |
| EX-21 - EXHIBIT 21 - Sucampo Pharmaceuticals, Inc. | exh_21.htm |
| EX-10.45 - EXHIBIT 10.45 - Sucampo Pharmaceuticals, Inc. | exh_1045.htm |
| EX-10.44 - EXHIBIT 10.44 - Sucampo Pharmaceuticals, Inc. | exh_1044.htm |
| 10-K - FORM 10-K - Sucampo Pharmaceuticals, Inc. | f10k_030817p.htm |
Exhibit 12.1
| Ratio of Earnings to Fixed Charges | ||||||||||||||||||||
| Year ended December 31, | ||||||||||||||||||||
| (in thousands, except for ratio) | 2016 | 2015 | 2014 | 2013 | 2012 | |||||||||||||||
| Pretax income from continuing operations | $ | 14,375 | $ | 43,675 | $ | 27,133 | $ | 10,943 | $ | 7,977 | ||||||||||
| Fixed charges: | ||||||||||||||||||||
| Interest expense | 23,761 | 6,854 | 1,520 | 1,894 | 2,346 | |||||||||||||||
| Earnings (a) | 38,136 | 50,529 | 28,653 | 12,837 | 10,323 | |||||||||||||||
| Fixed charges (b) | 23,761 | 6,854 | 1,520 | 1,894 | 2,346 | |||||||||||||||
| Ratio of earnings to fixed charges | 1.6 | 7.4 | 18.9 | 6.8 | 4.4 | |||||||||||||||